Global Gel Documentation Systems Market: Focus on Products, Source of Light, Detection Technology, Application, End User, Country Data (16 Countries), and Competitive Landscape – Analysis and Forecast, 2021-2030

$5,250$8,100

the gel documentation systems market to be one of the stable markets, and the global market is predicted to grow at a CAGR of 4.04% during the forecast period 2021-2030.

Clear

Description

Market Report Coverage – Gel Documentation Systems

Market Segmentation

• Products (Instruments, Accessories, and Software)
• Source of Light (Ultraviolet, Light Emitting Diodes, Laser and Others)
• Detection Technology (Fluorescence, Chemiluminescence, Colorimetric, and Other Detection Technologies)
• Application (Nucleic Acid Quantification, Protein Quantification, and Other Applications)
• End User (Academic and Research Institutions, Hospitals and Diagnostics Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organization and Other End Users)

Regional Segmentation

• North America: U.S., Canada
• Europe: Germany, France, Italy, U.K., Spain, Switzerland, and Rest-of-Europe
• Asia-Pacific: Japan, China, India, Australia, South Korea, Singapore, and Rest-of-APAC
• Latin America: Brazil, Mexico, Rest-of-Latin America
• Rest-of-the-World (RoW)

Market Growth Drivers

• Rising Prevalence of Genetic Disorders
• Increasing Research Funding in the Field of Genomics
• Increasing Number of Population Genomics Initiatives

Market Challenges

• Lack of High Complexity Genomic Testing Centers in High Potential Markets
• Challenges Pertaining to Genomic Data Centers
• Scarcity of Knowledge Dissemination Pertaining to Advanced Diagnostic Capabilities

Market Opportunities

• Massive Scope for Adoption of Genomic Data Analysis Software in Emerging Nations
• Novel Diagnostic Applications

Key Companies Profiled

Analytik Jena GmbH, Azure Biosystems, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cleaver Scientific, Clinx Science Instruments Co., Ltd., Danaher Corporation, Endress + Hauser Group, LI-COR, Inc., Merck KGaA, NIPPON Genetics Europe, PerkinElmer, Inc., Syngene, Thermo Fisher Scientific Inc., Vilber

Key Questions Answered in this Report:

• What are the major market drivers, challenges, and opportunities in the global gel documentation systems market?
• What are the underlying structures resulting in the emerging trends within the global gel documentation systems market?
• How is the COVID-19 pandemic impacting the global gel documentation systems market landscape?
• What are the key development strategies that are being implemented by the major players in order to sustain themselves in the competitive market?
• What are the key regulatory implications in developed and developing regions pertaining to gel documentation systems?
• What are the potential entry barriers, which are expected to be faced by the companies willing to enter a particular region for the development of gel documentation systems?
• How is each segment of the market expected to grow during the forecast period 2021-2030, and what is the anticipated revenue to be generated by each segment? Following are the segments:
o Products (instruments, accessories, and software)
o Source of light (UV, LEDs, laser, and others)
o Detection Technology (fluorescence, chemiluminescence, colorimetric, and other detection technologies)
o Application (nucleic acid quantification, protein quantification, and other applications)
o End user (academic and research institutions, hospitals and diagnostics laboratories, pharmaceutical and biotechnology companies, contract research organization, and other end users)
o Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
• What are the growth opportunities for the companies in the region of their operation?
• Who are the leading players with significant offerings in the global gel documentation systems market?
• Which companies are anticipated to be highly disruptive in the future, and why?
• What are the current unmet needs that are being faced in the global gel documentation systems market?

Market Overview

Gel documentation systems are used to image labeled protein samples and nucleic acid samples. Further, gel documentation systems are processed in a variety of configurations depending on throughput and sample type. Gel documentation systems measure labeled nucleic acid and protein in various types of media such as cellulose, agarose, or acrylamide. These systems come in a variety of configurations depending on sample type.

Our healthcare experts have found the gel documentation systems market to be one of the stable markets, and the global market is predicted to grow at a CAGR of 4.04% during the forecast period 2021-2030.

Factors fueling the growth of the market include the rising prevalence of genetic disorders, the increasing research funding in the field of genomics, and the growing number of population genomics initiatives. Despite rapid advanced industry growth, several key issues need to be addressed to facilitate future growth. The lack of high complexity genomic testing centers in high potential markets, challenges pertaining to genomic data storage, and scarcity of knowledge dissemination pertaining to advanced diagnostic capabilities are hampering the market growth. Further, some of the opportunities, such as massive scope for genomic data analysis software adoption in emerging nations, provide growth to the market.

Within the research report, the market has been segmented on the basis of products, source of light, detection technology, application, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in genetic disorders on the global level has created a buzz among companies to invest in advanced technologies such as gel documentation systems.

Based on region, North America holds the largest share, owing to improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. However, the Asia-Pacific and Europe regions are anticipated to grow at the fastest CAGR during the forecast period.

China Endoscope Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

1 Product Definition
1.1 Inclusion and Exclusion
2 Market Scope
2.1 Scope of the Study
2.2 Key Questions Answered in this Report
3 Research Methodology
3.1 Global Gel Documentation Systems Market: Research Methodology
3.2 Data Sources
3.2.1 Primary Data Sources
3.2.2 Secondary Data Sources
3.3 Market Estimation Model
3.4 Criteria for Company Profiling
4 Market Overview
4.1 Market Definition
4.2 Market Footprint and Growth Potential
4.3 COVID-19 Impact on Global Gel Documentation Systems Market
5 Market Dynamics
5.1 Overview
5.2 Impact Analysis
5.3 Market Drivers
5.3.1 Rising Prevalence of Genetic Disorders
5.3.2 Increasing Research Funding in the Field of Genomics
5.3.3 Increasing Number of Population Genomics Initiatives
5.4 Market Restraints
5.4.1 Lack of High Complexity Genomic Testing Centers in High Potential Markets
5.4.2 Challenges Pertaining to Genomic Data Storage
5.4.3 Scarcity of Knowledge Dissemination Pertaining to Advanced Diagnostic Capabilities
5.5 Market Opportunities
5.5.1 Massive Scope for Adoption of Genomic Data Analysis Software in Emerging Nations
5.5.2 Novel Diagnostic Applications
6 Industry Insights
6.1 Overview
6.2 Legal Requirements and Framework in the U.S.
6.2.1 Food and Drug Administration (FDA) Regulation
6.2.2 Centers for Medicare and Medicaid Services (CMS) Regulation
6.3 Legal Requirements and Framework in Europe
6.4 Legal Requirements and Framework in Asia-Pacific
6.4.1 China
6.4.2 Japan
7 Competitive Landscape
7.1 Acquisitions
7.2 Product Launches and Upgradations
7.3 Market Share Analysis (by Company), 2020
7.4 Growth Share Analysis
7.4.1 Growth Share Analysis (by Detection Technology)
8 Global Gel Documentation Systems Market (by Products), $Million, 2020-2030
8.1 Overview
8.2 Instruments
8.3 Accessories
8.4 Software
9 Global Gel Documentation Systems Market (by Source of Light), $Million, 2020-2030
9.1 Overview
9.2 UV
9.3 LEDs
9.4 Laser
9.5 Other Sources
10 Global Gel Documentation Systems Market (by Detection Technology), $Million, 2020-2030
10.1 Overview
10.2 Fluorescence
10.3 Chemiluminescence
10.4 Colorimetric
10.5 Other Detection Technologies
11 Global Gel Documentation Systems Market (by Application), $Million, 2020-2030
11.1 Overview
11.2 Nucleic Acid Quantification
11.3 Protein Quantification
11.4 Other Applications
12 Global Gel Documentation Systems Market (by End User), $Million, 2020-2030
12.1 Overview
12.2 Academic and Research Institutions
12.3 Hospitals and Diagnostic Laboratories
12.4 Pharmaceutical and Biotechnology Companies
12.5 Contract Research Organization
12.6 Other End Users
13 Global Gel Documentation Systems Market (by Region), $Million, 2020-2030
13.1 Overview
13.2 North America
13.2.1 U.S.
13.2.2 Canada
13.3 Europe
13.3.1 Germany
13.3.2 U.K.
13.3.3 France
13.3.4 Italy
13.3.5 Spain
13.3.6 Switzerland
13.3.7 Rest-of-Europe
13.4 Asia-Pacific
13.4.1 China
13.4.2 India
13.4.3 Japan
13.4.4 Australia
13.4.5 South Korea
13.4.6 Singapore
13.4.7 Rest-of-Asia-Pacific
13.5 Latin America
13.5.1 Brazil
13.5.2 Mexico
13.5.3 Rest-of-Latin America
13.6 Rest-of-the-World (RoW)
14 Company Profiles
14.1 Overview
14.2 Analytik Jena GmbH
14.2.1 Company Overview
14.2.2 Role of Analytik Jena GmbH in the Global Gel Documentation Systems Market
14.2.3 SWOT Analysis
14.3 Azure Biosystems, Inc.
14.3.1 Company Overview
14.3.2 Role of Azure Biosystems, Inc. in the Global Gel Documentation Systems Market
14.3.3 SWOT Analysis
14.4 Bio-Rad Laboratories, Inc.
14.4.1 Company Overview
14.4.2 Role of Bio-Rad Laboratories, Inc. in the Global Gel Documentation Systems Market
14.4.3 Financials
14.4.4 Key Insights About Financial Health of the Company
14.4.5 SWOT Analysis
14.5 Bio-Techne Corporation
14.5.1 Company Overview
14.5.2 Role of Bio-Techne Corporation in the Global Gel Documentation Systems Market
14.5.3 Financials
14.5.4 Key Insights About Financial Health of the Company
14.5.5 SWOT Analysis
14.6 Cleaver Scientific
14.6.1 Company Overview
14.6.2 Role of Cleaver Scientific in the Global Gel Documentation Systems Market
14.6.3 SWOT Analysis
14.7 Clinx Science Instruments Co., Ltd.
14.7.1 Company Overview
14.7.2 Role of Clinx Science Instruments Co., Ltd. in the Global Gel Documentation Systems Market
14.7.3 SWOT Analysis
14.8 Danaher Corporation
14.8.1 Company Overview
14.8.2 Role of Danaher Corporation in the Global Gel Documentation Systems Market
14.8.3 Financials
14.8.4 Key Insights About Financial Health of the Company
14.8.5 SWOT Analysis
14.9 Endress + Hauser Group
14.9.1 Company Overview
14.9.2 Role of Endress + Hauser Group in the Global Gel Documentation Systems Market
14.9.3 Financials
14.9.4 Key Insights About Financial Health of the Company
14.9.5 SWOT Analysis
14.1 LI-COR, Inc.
14.10.1 Company Overview
14.10.2 Role of in LI-COR, Inc. in the Global Gel Documentation Systems Market
14.10.3 SWOT Analysis
14.11 Merck KGaA
14.11.1 Company Overview
14.11.2 Role of Merck KGaA in the Global Gel Documentation Systems Market
14.11.3 Financials
14.11.4 Key Insights About Financial Health of the Company
14.11.5 SWOT Analysis
14.12 NIPPON Genetics Europe
14.12.1 Company Overview
14.12.2 Role of NIPPON Genetics Europe in the Global Gel Documentation Systems Market
14.12.3 SWOT Analysis
14.13 PerkinElmer, Inc.
14.13.1 Company Overview
14.13.2 Role of PerkinElmer, Inc. in the Global Gel Documentation Systems Market
14.13.3 Financials
14.13.4 SWOT Analysis
14.14 Syngene
14.14.1 Company Overview
14.14.2 Role of Syngene in the Global Gel Documentation Systems Market
14.14.3 SWOT Analysis
14.15 Thermo Fisher Scientific Inc.
14.15.1 Company Overview
14.15.2 Role of Thermo Fisher Scientific Inc. in the Global Gel Documentation Systems Market
14.15.3 Financials
14.15.4 Key Insights About Financial Health of the Company
14.15.5 SWOT Analysis
14.16 Vilber
14.16.1 Company Overview
14.16.2 Role of Vilber in the Global Gel Documentation Systems Market
14.16.3 SWOT Analysis
List of Tables
Table 5.1: Likert Scale
Table 5.2: Impact Analysis of Market Drivers
Table 5.3: Impact Analysis of Market Restraints
Table 8.1: Instruments Offered by Key Players
Table 8.2: Accessories Offered by Key Players
Table 8.2: Software Offered by Key Players
Table 9.1: Instruments Based on UV Light Source
Table 9.2: Instruments Based on LEDs Light Source
Table 9.3: Instruments Based on Laser Source
Table 9.4: Instruments Based on Other Sources
List of Figures
Figure 1: Annual NIH Funding in Human Genomics Research, FY2013-FY2019, $ Billion
Figure 2: Impact Analysis of Market Drivers and Market Challenges on Global Gel Documentation Systems Market
Figure 3: Global Gel Documentation Systems Market (by Products), $Million, 2020 vs. 2030
Figure 4: Global Gel Documentation Systems Market (by Detection Technology), $Million, 2020 vs. 2030
Figure 5: Global Gel Documentation Systems Market (by Application), $Million, 2020 vs. 2030
Figure 6: Global Gel Documentation Systems Market (by End User), $Million, 2020 vs. 2030
Figure 7: Global Gel Documentation Systems Market Snapshot
Figure 2.1: Global Gel Documentation Systems Market: Segmentation
Figure 3.1: Global Gel Documentation Systems Market: Research Methodology
Figure 3.2: Primary Research Methodology
Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.4: Top-Down Approach (Segment-Wise Analysis)
Figure 4.1: Global Gel Documentation Systems Market, $Million, 2020-2030
Figure 4.2: Global Gel Documentation Systems Market: COVID-19 Impact
Figure 5.1: Number of Patients Suffering from Cystic Fibrosis (CF), 2002-2019
Figure 6.1: FDA IVD Classification and Regulatory Process
Figure 6.2: Key Changes in EU IVD Regulation 2017/746
Figure 6.3: Medical Device Regulatory Approval Process in China
Figure 7.1: Share of Acquisitions (by Company), January 2017-May 2021
Figure 7.2: Number of Product Launches and Upgradations (by Company), January 2017–July 2021
Figure 7.3: Market Share Analysis for Global Gel Documentation Systems Market, 2020
Figure 7.4: Growth Share Analysis for Global Gel Documentation Systems Market (by Detection Technology), 2020-2031
Figure 8.1: Global Gel Documentation Systems Market (by Products)
Figure 8.2: Global Gel Documentation Systems Market (by Products), 2020-2030
Figure 8.3: Global Gel Documentation Systems Market (Instruments), $Million, 2020-2030
Figure 8.4: Global Gel Documentation Systems Market (by Instruments), 2020-2030
Figure 8.5: Global Gel Documentation Systems Market (Accessories), $Million, 2020-2030
Figure 8.6: Global Gel Documentation Systems Market (Software), $Million, 2020-2030
Figure 9.1: Global Gel Documentation Systems Market (by Source of Light)
Figure 9.2: Global Gel Documentation Systems Market (by Source of Light), $Million, 2020-2030
Figure 9.3: Global Gel Documentation Systems Market (UV), $Million, 2020-2030
Figure 9.4: Global Gel Documentation Systems Market (LEDs), $Million, 2020-2030
Figure 9.5: Global Gel Documentation Systems Market (Laser), $Million, 2020-2030
Figure 9.6: Global Gel Documentation Systems Market (Other Sources), $Million, 2020-2030
Figure 10.1: Global Gel Documentation Systems Market (by Detection Technology)
Figure 10.2: Global Gel Documentation Systems Market (by Detection Technology), 2020-2030
Figure 10.3: Global Gel Documentation Systems Market (Fluorescence), $Million, 2020-2030
Figure 10.4: Global Gel Documentation Systems Market (Chemiluminescence), $Million, 2020-2030
Figure 10.5: Global Gel Documentation Systems Market (Colorimetric), $Million, 2020-2030
Figure 10.6: Global Gel Documentation Systems Market (Other Detection Technologies), $Million, 2020-2030
Figure 11.1: Global Gel Documentation Systems Market (by Application)
Figure 11.2: Global Gel Documentation Systems Market (by Application), $Million, 2020-2030
Figure 11.3: Global Gel Documentation Systems Market (Nucleic Acid Quantification), $Million, 2020-2030
Figure 11.4: Global Gel Documentation Systems Market (Protein Quantification), $Million, 2020-2030
Figure 11.5: Global Gel Documentation Systems Market (Other Applications), $Million, 2020-2030
Figure 12.1: Global Gel Documentation Systems Market (by End User)
Figure 12.2: Global Gel Documentation Systems Market (by End User), $Million, 2020-2030
Figure 12.3: Global Gel Documentation Systems Market (Academic and Research Institutions), $Million, 2020-2030
Figure 12.4: Global Gel Documentation Systems Market (Hospitals and Diagnostic Laboratories), $Million, 2020-2030
Figure 12.5: Global Gel Documentation Systems Market (Pharmaceutical and Biotechnology Companies), $Million, 2020-2030
Figure 12.6: Global Gel Documentation Systems Market (Contract Research Organization), $Million, 2020-2030
Figure 12.7: Global Gel Documentation Systems Market (Other End Users), $Million, 2020-2030
Figure 13.1: Global Gel Documentation Systems Market (by Region), 2020 and 2030
Figure 13.2: Global Gel Documentation Systems Market (by Region), $Million, 2020-2030
Figure 13.3: Global Gel Documentation Systems Market (by Region), 2020-2030
Figure 13.4: North America Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.5: North America: Market Dynamics
Figure 13.6: North America Gel Documentation Systems Market (by Country), $Million, 2020-2030
Figure 13.7: U.S. Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.8: Canada Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.9: Europe Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.10: Europe: Market Dynamics
Figure 13.11: Europe Gel Documentation Systems Market (by Country), $Million, 2020-2030
Figure 13.12: Germany Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.13: U.K. Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.14: France Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.15: Italy Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.16: Spain Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.17: Switzerland Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.18: Rest-of-Europe Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.19: Asia-Pacific Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.20: APAC: Market Dynamics
Figure 13.21: APAC Gel Documentation Systems Market (by Country), $Million, 2020-2030
Figure 13.22: China Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.23: India Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.24: Japan Gel documentation Systems Market, $Million, 2020-2030
Figure 13.25: Australia Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.26: South Korea Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.27: Singapore Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.28: RoAPAC Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.29: Latin America Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.30: Latin America: Market Dynamics
Figure 13.31: Latin America Gel Documentation Systems Market (by Country), $Million, 2020-2030
Figure 13.32: Brazil Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.33: Mexico Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.34: Rest-of-Latin America Gel Documentation Systems Market, $Million, 2020-2030
Figure 13.35: RoW Gel Documentation Systems Market, $Million, 2020-2030
Figure 14.1: Total Number of Companies Profiled
Figure 14.2: Analytik Jena GmbH: Key Product Portfolio
Figure 14.3: Analytik Jena GmbH: SWOT Analysis
Figure 14.4: Azure Biosystems, Inc.: Product Portfolio
Figure 14.5: Azure Biosystems, Inc.: SWOT Analysis
Figure 14.6: Bio-Rad Laboratories, Inc.: Product Portfolio
Figure 14.7: Bio-Rad Laboratories, Inc.: Overall Financials, 2018-2020
Figure 14.8: Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2018-2020
Figure 14.9: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2018-2020
Figure 14.10: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2018-2020
Figure 14.11: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 14.12: Bio-Techne Corporation: Product Portfolio
Figure 14.13: Bio-Techne Corporation: Overall Financials, 2018-2020
Figure 14.14: Bio-Techne Corporation: Revenue (by Segment), 2018-2020
Figure 14.15: Bio-Techne Corporation: Revenue (by Region), 2018-2020
Figure 14.16: Bio-Techne Corporation: R&D Expenditure, 2018-2020
Figure 14.17: Bio-Techne Corporation: SWOT Analysis
Figure 14.18: Cleaver Scientific: Product Portfolio
Figure 14.19: Cleaver Scientific: SWOT Analysis
Figure 14.20: Clinx Science Instruments Co., Ltd.: Product Portfolio
Figure 14.21: Clinx Science Instruments Co., Ltd.: SWOT Analysis
Figure 14.22: Danaher Corporation: Product Portfolio
Figure 14.23: Danaher Corporation: Overall Financials, 2018-2020
Figure 14.24: Danaher Corporation: Revenue (by Segment), 2018-2020
Figure 14.25: Danaher Corporation: Revenue (by Region), 2018-2020
Figure 14.26: Danaher Corporation: R&D Expenditure, 2018-2020
Figure 14.27: Danaher Corporation: SWOT Analysis
Figure 14.28: Endress + Hauser Group: Overall Financials, 2018-2020
Figure 14.29: Endress + Hauser Group: Revenue (by Segment), 2018-2020
Figure 14.30: Endress + Hauser Group: Revenue (by Region), 2018-2020
Figure 14.31: Endress + Hauser Group: R&D Expenditure, 2018-2020
Figure 14.32: Endress + Hauser Group: SWOT Analysis
Figure 14.33: LI-COR, Inc.: Product Portfolio
Figure 14.34: LI-COR, Inc.: SWOT Analysis
Figure 14.35: Merck KGaA: Key Product Offerings
Figure 14.36: Merck KGaA: Overall Financials, 2018-2020
Figure 14.37: Merck KGaA: Revenue (by Segment), $Million, 2018-2020
Figure 14.38: Merck KGaA: Revenue (by Region), 2018-2020
Figure 14.39: Merck KGaA: R&D Expenditure, 2018-2020
Figure 14.40: Merck KGaA: SWOT Analysis
Figure 14.41: NIPPON Genetics Europe: Key Product Portfolio
Figure 14.42: NIPPON Genetics Europe: SWOT Analysis
Figure 14.43: PerkinElmer, Inc.: Key Product Portfolio
Figure 14.44: Perkin Elmer, Inc.: Overall Financials, (2018-2020)
Figure 14.45: Perkin Elmer, Inc.: Revenue (by Segment), 2018-2020
Figure 14.46: Perkin Elmer, Inc.: Revenue (by Region), 2018-2020
Figure 14.47: PerkinElmer, Inc.: R&D Expenditure, 2018-2020
Figure 14.48: PerkinElmer, Inc.: SWOT Analysis
Figure 14.49: Syngene: Product Portfolio
Figure 14.50: Syngene: SWOT Analysis
Figure 14.51: Thermo Fisher Scientific, Inc.: Product Portfolio
Figure 14.52: Thermo Fisher Scientific Inc.: Overall Financials, 2018-2020
Figure 14.53: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2018-2020
Figure 14.54: Thermo Fisher Scientific Inc.: Revenue (by Region), 2018-2020
Figure 14.55: Thermo Fisher Scientific Inc.: R&D Expenditure, 2018-2020
Figure 14.56: Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 14.57: Vilber: Product Portfolio
Figure 14.58: Vilber.: SWOT Analysis

RSS
Follow by Email